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Retinitis pigmentosa (RP) and age-related macular
degeneration (AMD) are blinding diseases caused
by the degeneration of rods and cones, leaving the
remainder of the visual system unable to respond to
light. Here, we report a chemical photoswitch named
DENAQ that restores retinal responses to white light
of intensity similar to ordinary daylight. A single intra-
ocular injection of DENAQ photosensitizes the blind
retina for days, restoring electrophysiological and
behavioral responses with no toxicity. Experiments
on mouse strains with functional, nonfunctional, or
degenerated rods and cones show that DENAQ
is effective only in retinas with degenerated photo-
receptors. DENAQ confers light sensitivity on a
hyperpolarization-activated inward current that is
enhanced in degenerated retina, enabling optical
control of retinal ganglion cell firing. The acceptable
light sensitivity, favorable spectral sensitivity, and se-
lective targeting to diseased tissue make DENAQ a
primedrugcandidate for vision restoration inpatients
with end-stage RP and AMD.
INTRODUCTION
Degenerative retinal diseases, including age-related macular
degeneration (AMD) and retinitis pigmentosa (RP), affect millions
of people around the world. At present, there are no effective
treatments to prevent the progressive degeneration of rod and
cone photoreceptors that characterizes these disorders.Without
a means for restoring photoreception, patients with advanced
RP face the prospect of irreversible blindness. Several technol-
ogies are being developed to confer information about the visual
world to the retinal neurons that survive after the rods and cones
have degenerated. Surgically implanted electronic retinal pros-800 Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc.thetics can electrically stimulate RGC firing, restoring some
visual perception to blind humans (Weiland et al., 2011). Trans-
plantation of stem cell-derived photoreceptors can restore
retinal light responses to blind mice (Lamba et al., 2009), and a
retinal pigment epithelium transplant has improved vision in a
patient with AMD (Schwartz et al., 2012). Viral expression of mi-
crobial opsins (Busskamp et al., 2010; Lagali et al., 2008; Thya-
garajan et al., 2010) or other optogenetic tools (Caporale et al.,
2011) can restore visual responses in blind mouse models of
RP. All of these strategies have shown promise for restoring
visual function, but they are either invasive (i.e., implantation of
electronic chips) or irreversible (i.e., transplantation of photore-
ceptor progenitors or viral expression of optogenetic tools).
The potential permanence of stem cell or gene therapies could
be a benefit if complications are absent, but the possibility of irre-
versible adverse effects makes these interventions potentially
risky to implement in humans.
We recently introduced another strategy for restoring visual
function: adding a synthetic small molecule ‘‘photoswitch’’ to
confer light sensitivity onto retinal neurons without involving
exogenous gene expression.We showed that a photoswitchable
K+ channel blocker named AAQ could bestow light responses
onto retinal ganglion cells (RGCs) and restore light-elicited
behavior in blind mice in vivo (Polosukhina et al., 2012). As a
drug-like small molecule, AAQ has some potential advantages
over the other approaches for vision restoration. Unlikemicrobial
opsin or stem cell-based therapies, the effect of AAQ is revers-
ible, allowing the dosage to be adjusted to maximize efficacy
and minimize toxicity. Furthermore, photoswitch compounds
diffuse freely and photosensitize neurons throughout the entire
retina. This ensures broader coverage and higher spatial resolu-
tion than a retinal implant, which covers only a small area of the
retina with stimulating electrodes that are spaced further apart
than the packing density of RGCs.
Unfortunately, several properties of AAQ limit its potential for
therapeutic development. AAQ requires high-intensity UV light
and dissipates from the eye within a day after intravitreal injec-
tion. The human lens filters out most UV light (Artigas et al.,
2012), and repeated exposure to high-intensity light can be
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sitate daily injections of the compound into the eye, a delivery
schedule unsuitable for long-term treatment. Furthermore,
AAQcontains a reactive acrylamidemoiety, and its toxicity in vivo
is unknown. In an attempt to overcome these shortcomings,
we have turned to a red-shifted K+ channel photoswitch called
DENAQ, which exhibits trans to cis photoisomerization with
visible light (450–550 nm) and relaxes rapidly to the trans config-
uration in the dark (Mourot et al., 2011).
RESULTS
DENAQ Restores Photopic Light Responses to the
Degenerating Mouse Retina
DENAQ is a red-shifted photoswitch compound (Figure 1A) that
confers light sensitivity on voltage-gated ion channels (Mourot
et al., 2011, 2013). We tested the action of DENAQ on the retinas
of 3- to 6-month-old rd1 mice, which lose nearly all rods and
cones within 1 month after birth (Sancho-Pelluz et al., 2008).
We measured the effect of light on action potential firing
by RGCs recorded with an extracellular multielectrode array
(MEA). Before photoswitch application, light caused no signifi-
cant change in firing rate (Figure 1B). Treatment with 300 mM
DENAQ for 30 min photosensitized the retina, such that nearly
all RGCs responded to the onset of a 15 s light flash with an
increase in firing rate (Figure 1C). On average, DENAQ-treated
RGCs generated a significant firing rate increase within
20 ms of light onset (p < 0.05), reaching their peak firing within
400 ms. Thereafter, the firing frequency declined during the
flash. Azobenzene photoswitches reach a stable photostation-
ary state with sustained illumination (Fischer et al., 1955), so
the decline in firing rate is likely a consequence of spike-fre-
quency adaptation intrinsic to RGCs rather than the photochem-
ical properties of DENAQ. At light offset, the average firing rate
across all units returned to baseline within 600 ms, but >20%
of units recovered within 100 ms. The decay of the DENAQ-
mediated response at light offset is dependent on fast cis to trans
thermal relaxation (Mourot et al., 2011), in contrast to AAQ, which
persists in the cis state for >10 min and needs to be reset with
green light (Fortin et al., 2008).
We next examined the spectral sensitivity of DENAQ-medi-
ated photosensitization of the rd1 retina. A wide range of wave-
lengths between400 and550 nmcan elicit the light response,
with blue-green light (480–500 nm) being most effective in
the visible range (Figure 1D). The action spectrum of retinal
photosensitization closely matches the absorption spectrum of
trans-DENAQ in solution (Mourot et al., 2011). Stimulation with
broad-spectrum white light is also effective. To quantify the de-
gree of photosensitization for each RGC, we calculated the light
response index (LRI) (previously designated the ‘‘photoswitch in-
dex’’; Polosukhina et al., 2012). The LRI is the normalized change
in average firing rate upon switching from darkness to white
light. RGCs from untreated rd1 retinas showed no detectable
light response (median LRI = 0, n = 12 retinas), while nearly all
RGCs treated with DENAQwere activated by white light (median
LRI = 0.42, n = 12 retinas; p < 0.001, rank sum test) (Figure 1E).
For every untreated retina studied, light caused no significant
change in firing rate (n = 12, p = 0.94) (Figure 1F), while for everyDENAQ-treated retina, light elicited a significant increase in firing
rate (mean increase = 2.4-fold, n = 12; p < 0.001) (Figure 1G).
The light intensity threshold for triggering RGC firing was 4 3
1013 photons/cm2/s for DENAQ (Figure 2A). More RGCs could
be recruited to respond by increasing light intensity, with 1
log unit above threshold (3 3 1014 photons/cm2/s) needed to
generate a response in >50% of RGCs (Figure 2B). For compar-
ison, the threshold for responses mediated by AAQ (Polosukhina
et al., 2012), ChR2 expressed in RGCs (Thyagarajan et al., 2010),
and halorhodopsin (NpHR) expressed in remnant cones (Bus-
skamp et al., 2010) was 4 3 1015, 1 3 1014, and 2 3 1014 pho-
tons/cm2/s, respectively. Thus, the sensitivity of DENAQ-treated
retinas is as high as, if not higher than, that of retinas expressing
these microbial optogenetic tools. New optogenetic tools with
improved light sensitivity (Chow et al., 2010) are available but
have not yet been tested for vision restoration.
Photosensitivity can also be conferred to the rd1 retina by
injecting DENAQ into the vitreous cavity of eye in vivo. MEA re-
cordings at later times after injection showed that DENAQphoto-
sensitization persists for several days (half-life = 2.1 days), in
contrast to AAQ, which dissipates within 12 hr after intravitreal
injection (half-life = 3.6 hr) (Figure 2C). The lifetime of the com-
pounds in the eye mirrors their relative lipophilicity, with the
more hydrophobic DENAQ persisting longer than AAQ.
We characterized the receptive field properties of DENAQ-
treated RGCs. Illumination of the retina with a small spot of light
resulted in an increase in activity in stimulated RGCs (median
LRI = 0.45, n = 16 cells), but the surrounding unilluminated
RGCs showed no change in firing rate (median LRI = 0.01,
n = 741 cells; p < 0.001, rank sum test) (Figures 3A and 3B; Table
S1 available online). Since only targeted neurons near a single
electrode showed a light response and since individual RGCs
are detected by only one electrode on the MEA (which are
spaced 200 mm apart), we can estimate that the DENAQ-medi-
ated RGC collecting area is at most 200 mm in diameter.
Indeed, as we stimulated with expanding spots of light, the
RGC response increased with larger spot size and saturated
at an average spot diameter of 240 mm (Figure 3C). No further in-
crease in light response was observed with spot sizes greater
than 240 mm or with full-field stimulation. The estimated recep-
tive field size of DENAQ-treated RGCs matches previous mea-
surements of mouse RGC dendritic fields, which average
200 mm in diameter (Ren et al., 2010). Stimulation with small,
30-mm-diameter light spots was sufficient to drive RGC activity,
suggesting that neighboring RGCs could, in principle, be manip-
ulated independently with a precise stimulus, offering a basis for
high-acuity vision. RGCs in AAQ-treated retina have different
receptive field properties because chemical photosensitization
applies to both RGCs and inhibitory amacrine cells, leading to
an antagonistic center-surround response (Polosukhina et al.,
2012).
DENAQ Selectively Photosensitizes Retinas with
Degenerated Rods and Cones
Photoreceptor degeneration in RP progresses from the periph-
eral to the central retina, which in some patients can remain dis-
ease-free for years (Milam et al., 1998). In AMD, the pattern is
reversed, with photoreceptor degeneration largely restricted toNeuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc. 801
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Figure 1. The Red-Shifted Photoswitch DENAQ Restores Light Responses to Blind Retinas from rd1 Mice
(A) Molecular structure of DENAQ. Light converts DENAQ from the trans to the cis form, and the compound quickly relaxes back to the trans form in the dark.
(B and C) MEA recording from an rd1 retina before (B) and after treatment with 300 mM DENAQ (C). Horizontal bar shows light and dark episodes.
(D) Spectral sensitivity of the DENAQ-mediated light response.
(E) LRI value distributions for RGCs from untreated (black) (median LRI = 0, n = 12 retinas) and DENAQ-treated (blue) rd1 retinas (median LRI = 0.42, n = 12 retinas;
p < 0.001, rank sum test).
(F and G) DENAQ restored light responses in every retina tested. Mean RGC firing rate for each retina in light and darkness before (n = 12 retinas, p = 0.94) (F) and
after DENAQ treatment (n = 12 retinas, p < 0.001) (G) is shown. Mean ± SEM values are shown in red.
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Figure 2. Intensity Requirement for Restoring Light Responses and Persistence of DENAQ in the Eye
(A) Light intensity versus response curve for DENAQ (n = 5 retinas). Data are mean ± SEM. Labeled dotted lines represent the thresholds for activation of DENAQ
(blue), ChR2 (Thyagarajan et al., 2010) (red), NpHR (Busskamp et al., 2010) (red), and AAQ (Polosukhina et al., 2012) (red) in the retina.
(B) MEA recording from a DENAQ-treated rd1 retina stimulated with moderate intensity (3 3 1014 photons/cm2/s) white light. Light (white) and dark (black)
episodes are shown by the horizontal bar above the recording.
(C) Persistence of photosensitization elicited by in vivo injection of AAQ (red; half-life = 3.6 hr) and DENAQ (blue; half-life = 2.1 days). Responses were measured
on theMEA ex vivo, hours to days after in vivo injection of 2 ml of 20mMphotoswitch (n = 4 retinas per time point). Photoswitch half-life was calculated by fitting the
data with a monoexponential decay function.
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that restores photosensitivity, it would be preferable if the treat-
ment selectively acted on diseased retinal regions while sparing
healthy tissue. To assess the actions of photoswitch compounds
on healthy and diseased retina, we compared the effects of
DENAQ in wild-type (WT) versus rd1 retinas. The light-stimulus
parameters were the same as those shown in Figure 1. The WT
retina is naturally sensitive to light, so not surprisingly, almost
all RGCs exhibited strong light responses, with light onset trig-
gering an increase in firing in some neurons (ON-RGCs) and a
decrease in others (OFF-RGCs) (Figure 4A). However, it was
surprising to find that DENAQ treatment caused no change in
the light response of theWT retina, with no difference in the num-
ber of RGCs generating on versus off responses (Figure 4B). To
quantify this comparison, we calculated for each RGC the peak
light response index (PLRI), which represents the normalized
change in peak firing rate upon switching from darkness to light.
Plotting the PLRI for each RGC reveals the distribution of neu-
rons exhibiting primarily on versus off behavior (Figure 4C). We
found no significant difference in the PLRI distribution before
and after DENAQ treatment (n = 6 retinas; p = 0.34, rank sum
test). Hence, at least according to this measure, DENAQ has
no effect on the response properties of the WT retina, in stark
contrast to its effect on the rd1 retina.
The rd1 retina differs from the WT retina in several ways. Not
only have the rods and cones degenerated, which leads to
changes in growth factor release (Amendola et al., 2003), but
also the neural circuitry of the retina no longer processes light-
driven signals, which leads to homeostatic changes in synaptic
transmission and neuronal excitability (Marc et al., 2003; Sekirn-
jak et al., 2011; Stasheff, 2008). To test whether the loss of
light-driven signals is sufficient for enabling DENAQ photosensi-
tization, we tested DENAQ on retinas from a triple-knockout
(TKO) mouse (tra/ cnga3/ opn4/). The TKO mouse has
the normal complement of structurally intact rods and cones,but light responsiveness in these cells has been impaired
because of the loss of essential phototransduction proteins
(Hattar et al., 2003). Also lacking is melanopsin, the photopig-
ment of intrinsically photosensitive RGCs. As expected, TKO
retinas did not respond to white-light stimulation, but the retinas
remained unresponsive even after DENAQ treatment (n = 6
retinas; p = 0.21, rank sum test) (Figure 4D). The lack of
photosensitization suggests that the mere presence of intact
photoreceptors, even if they are not light sensitive, is sufficient
to prevent DENAQ action.
We further tested the role of rod and cone degeneration in
DENAQ photosensitization by evaluating the effectiveness of
the photoswitch in a different mouse model of RP. Rd4 mice
have a null mutation in rod transducin (Kitamura et al., 2006),
whereas rd1 mice suffer from a null mutation in rod phosphodi-
esterase (Bowes et al., 1990). The rods and cones degenerate
soon after birth in both of these mouse strains, leading to
complete blindness by 6 weeks of age (Roderick et al., 1997;
Sancho-Pelluz et al., 2008). As expected, untreated retinas
from 3- to 6-month-old rd4 mice did not generate a light
response, but DENAQ treatment did confer robust light re-
sponses (n = 6 retinas; p < 0.001, rank sum test) (Figure 4D),
just like in the rd1 retina. Thus, it seems that rod and cone degen-
eration itself, and not any particular mutation, is what enables
DENAQ photosensitization.
Mechanism of Degeneration-Specific
Photosensitization by DENAQ
In animal models of RP, the degeneration of rods and cones
leads to an increase in the spontaneous firing rate of RGCs
(Sekirnjak et al., 2011; Stasheff, 2008). The mechanism of this
electrophysiological remodeling is unknown, but at least part
of the hyperactivity is intrinsic to the RGCs themselves (Sekirnjak
et al., 2011). To test whether RGCs are a target for DENAQ in
degenerating retina, we applied a cocktail of neurotransmitterNeuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc. 803
A B
C
Figure 3. The DENAQ-Treated rd1 Retina
Generates Spatially Precise Light Re-
sponses
(A) Targeted illuminationof aportion of an rd1 retina
centered on a single MEA electrode (top). Elec-
trode E4 was stimulated with a 60-mm-diameter
light spot. Only the targeted electrode recorded a
large increase in RGC firing in response to white
light (bottom). PI values are color-coded (scale at
left) andalso representedbybar height. Theorange
bar is electrode E4. Empty squares are electrodes
on which no action potentials were recorded.
(B) Targeted illumination elicits an increase in ac-
tivity in stimulated RGCs and has no effect on
surrounding RGCs (n = 16 cells and n = 741 cells,
respectively, from seven retinas). LRI values of
RGCs (black circles) as a function of distance from
the target electrode, displayed in 200 mm bins.
Median plus and minus the 95% confidence in-
tervals are shown in red.
(C) Responses of DENAQ-treated rd1 RGCs to
stimulationwithspotsof lightof increasingdiameter.
The light response saturates at 240-mm-diameter
spot size. Data are mean ± SEM; n = 20 cells.
See also Table S1.
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GABA-, acetylcholine-, and glycine-mediated synaptic transmis-
sion. Under these conditions, RGCs continued to generate an
increase in firing frequency in response to light (mean LRI =
0.70, n = 8 retinas) (Figures 5A and 5C). In fact, rather than being
reduced by synaptic blockade, the light response of RGCs was
increased, mainly due to a reduction in spontaneous firing in
the dark. Similar results were obtained from RGCs in DENAQ-
treated rd4 retinas, which also continued to show light re-
sponses after synaptic blockade (mean LRI = 0.43, n = 6 retinas)
(Figure 5C). Control experiments showed that the cocktail
completely eliminated light-elicited changes in RGC firing medi-
ated by normal rod and cone phototransduction in WT retina
(Figure S1), confirming that blockade of retinal synaptic trans-
mission was effective (Wong et al., 2007).
In contrast to the effects on degenerating retina, DENAQ failed
to photosensitize pharmacologically isolated RGCs inWT retinas
(mean LRI =0.01, n = 10 retinas) (Figures 5B and 5C) and in ret-
inas from TKO mice (mean LRI = 0, n = 6 retinas) (Figure 5C).
Hence, while RGCs from degenerated retinas are strongly pho-
tosensitized by DENAQ, RGCs from healthy retinas are DENAQ
insensitive. These results indicate that the primary cellular locus
for DENAQ photosensitization is the RGC. This is different from
AAQ photosensitization, which is mediated primarily by ama-
crine cells (Polosukhina et al., 2012).
We explored differences between rd1 and WT retinas that
might account for degeneration-specific DENAQ photosensiti-
zation. It seemed possible that DENAQ might have greater ac-
cess to RGCs in degenerating retina, perhaps due to changes
in the integrity or permeability of the inner limiting membrane
(ILM) or outer limiting membrane (OLM). To test whether the
ILM or OLM acts as a barrier to prevent DENAQ photosensitiza-
tion, we disrupted bothmembranes in theWT retina with a series
of transverse cuts made by a sharp razor blade. Subsequent
DENAQ treatment of these retinal slices failed to produce any804 Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc.photosensitization (mean LRI = 0.03, n = 6 retinas; p = 0.62) (Fig-
ure S2). This experiment indicates that poor accessibility cannot
account for the DENAQ insensitivity of the WT retina.
Since DENAQ access is not the issue, perhaps the selectivity
of DENAQ for the degenerating retina is caused by a change
in conductances photosensitized by DENAQ. To compare the
photosensitization of ionic conductances in WT and rd1 RGCs,
we obtained whole-cell patch-clamp recordings after DENAQ
treatment. We used the same cocktail of receptor antagonists
to eliminate synaptic transmission, thereby revealing light-
elicited effects on intrinsic conductances. Membrane potential
was held at 60 mV, and a series of test pulses from 100 mV
to 0 mV was delivered to activate voltage-gated ion channels.
Figures 6A–6C compare the current-voltage (I-V) relationships
of representative WT and rd1 RGCs, and Figure 6D shows
average data from all WT and rd1 RGCs. In the RGC from the
WT retina, light resulted in a small increase in the outward current
elicited by depolarization above 40 mV, consistent with photo-
regulation of voltage-gated K+ current (IK) (Figures 6A, 6C, and
S3A). On average, light elicited a 15% increase in IK (Figure 6D).
However, light had no effect on ionic current near the resting po-
tential (70mV) or on the hyperpolarization-activated current, Ih,
elicited by steps to 100 mV (Figures 6A, 6C, 6D, and S3A).
In contrast, in the RGC from the rd1 retina, DENAQ conferred
light sensitivity on ion channels that were active at both depolar-
ized and hyperpolarized membrane potentials (Figures 6B and
6C). At potentials positive to40mV, light resulted in an increase
in IK not significantly different from the effect of DENAQ on WT
RGCs (Figure 6D; mean increase = 23%, p = 0.2). However,
unique to the rd1 cell, light also increased Ih (Figures 6B, 6C,
and S3B). On average, light increased Ih by 20% in 11 RGCs
tested (Figure 6D; p < 0.001). At membrane potentials below
50 mV, light caused a steady inward current that would depo-
larize the cell if it had not been voltage clamped. The light-
regulated current increased nonlinearly between 50 mV
A B
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Figure 4. DENAQ Only Photosensitizes Retinas in which Rod and Cone Photoreceptors Have Degenerated
(A and B) MEA recording from a WT retina before (A) and after (B) treatment with 300 mM DENAQ.
(C) RGC PLRI values for WT retinas before (black) and after (blue) DENAQ treatment (n = 6 retinas; p = 0.34, rank sum test).
(D) Light responses of untreated and DENAQ-treatedWT (n = 6, p = 0.72), TKO (n = 6, p = 0.97), rd1 (n = 12, p < 0.001), and rd4 retinas (n = 6, p < 0.001). Mean PLRI
values are shown for WT retinas and mean LRI values for TKO, rd1, and rd4 retinas. Data are mean ± SEM.
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described in many neurons, including RGCs (Lee and Ishida,
2007; Stradleigh et al., 2011). A comparison of the light-elicited
currents across numerous WT and rd1 RGCs (Figure 6D) con-
firms that DENAQ only affects Ih in the rd1 RGCs. We propose
that enhancement of Ih, owing to the light-elicited relief of
DENAQ channel blockade, is the primary cause of light-elicited
RGC firing.
RGCs from rd1 retina have amore depolarized average resting
potential and a higher basal firing rate in darkness than RGCs
from WT retinas (Figures 6A and 6B; Stasheff, 2008). We found
that the current density of Ih is significantly larger in rd1 RGCs
(6.4 pA/pF) than in WT RGCs (2.9 pA/pF; p < 0.01) (Figure 6E),consistent with enhanced excitability. However, the 2-fold in-
crease in current density seems insufficient to fully account for
the dramatic difference in the light response, suggesting that
there are additional differences in the properties of channels un-
derlying Ih in rd1 RGCs. IK is slightly larger in rd1 RGCs, but the
difference from WT RGCs is not statistically significant (p = 0.3).
To confirm that photosensitization of Ih mediates the DENAQ
light response, we obtained MEA recordings from rd1 retinas
treated with three different Ih inhibitors. The light response was
completely eliminated by ZD7288 (100 mM), a widely used
blocker of Ih (Postea and Biel, 2011). However, this blocker
reduced the basal firing rate of RGCs in darkness (Figure 6F)
and is known to inhibit certain voltage-gated Na+ channels (WuNeuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc. 805
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Figure 5. DENAQ Selectively Photosensitizes RGCs from Retinas with Degenerated Photoreceptors
(A and B) MEA recording from pharmacologically isolated rd1 (A) and WT (B) RGCs.
(C) Light responses of pharmacologically isolatedWT RGCs (mean LRI =0.01, n = 10 retinas; p < 0.001), TKO RGCs (mean LRI = 0, n = 6 retinas; p < 0.001), rd1
RGCs (mean LRI = 0.70, n = 8 retinas), and rd4 RGCs (mean LRI = 0.43, n = 6 retinas).
See also Figures S1 and S2.
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radine (50 mM) and cilobradine (50 mM), which are more specific
for Ih (Postea and Biel, 2011) and do not noticeably decrease
basal RGC activity (Figure 6F). Both of these drugs completely
eliminated the DENAQ-mediated light response (Figures 6F
and 6G). Similar results were obtained in DENAQ-treated retinas
in the absence of synaptic blockers (Figure S4). Hence, blockade
of DENAQ-mediated photosensitization by Ih inhibitors is inde-
pendent of changes in basal RGC firing rate.
DENAQ Is Nontoxic
In order to assess the safety of DENAQ in vivo, we performed a
histological analysis of WT retinas at 10 and 30 days postinjec-
tion (DPI) of PBS alone (sham) or PBS containing 5 mM DENAQ.
No pathological changes were observed in either the DENAQ-
injected or sham-injected retinas (Figure S5A). To determine
whether DENAQ caused apoptosis of retinal neurons, we per-
formed a TUNEL assay, which stains cells with nicked DNA, a
marker of apoptosis (Loo, 2011). Apoptotic cells were extremely
rare (<0.2%) (Figures S5A and S5B) and did not significantly
differ in number between DENAQ- and sham-injected retinas
(p10 day = 0.16, p30 day = 0.13). In contrast, DNase I-treated retinas
displayed extensive apoptosis, with 70% of retinal neurons
staining positive in the TUNEL assay (Figures S5A and S5B).
There was no significant difference between sham- and
DENAQ-treated retinas in the thickness of the outer nuclear layer
(p10 day = 0.92, p30 day = 0.77) or the inner nuclear layer (p10 day =
0.39, p30 day = 0.73) (Figure S5C). Finally, there was no change in
RGC density (cells per 100 mm) in the central (p = 0.62) or periph-
eral retina (p = 0.1) (Figure S5D).
DENAQ Enables Innate and Learned Behavioral Light
Responses in Blind Mice
We next evaluated the ability of DENAQ to restore light-elicited
behavior in vivo. Blind rd1 mice showed no difference in explor-
atory behavior during 5 min spent in green light versus 5 min in
darkness in an open-field locomotory assay (Figures 7A and
7B). Six hours after intravitreal injection of DENAQ, individual806 Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc.mice displayed an increase in locomotory activity in light as
compared to darkness (Figures 7A and 7B). Before DENAQ
treatment, the average velocity of movement for 20 mice tested
was the same indarkness as in light,whereas after treatment their
movement was faster in light than in darkness (Figure 7C). The
greatest increase in exploratory behavior was observed in the
first 100 s of the light (mean ratio = 1.74, n = 20; p < 0.001) (Fig-
ure 7C) and then diminished at later time points, most likely due
to habituation. This increase in light-elicited locomotion is consis-
tent with previously reported results from rd1 mice expressing
ChR2 in ON-bipolar cells (Lagali et al., 2008). Sham injection of
PBS produced no significant change in basal activity or activity
in light versus darkness (n = 6; p = 0.88) (Figure 7C).
Whatever vision-restoration technology is ultimately em-
ployed, regaining normal sensory perception, including visual
object recognition, will almost certainly require learning. To test
whether rd1 mice can use the DENAQ-mediated light response
as a stimulus for a learned behavior, we used a visual-cued
fear-conditioning assay. In normally sighted mice, this classical
conditioning paradigm associates a light cue with an electric
foot shock, such that subsequent exposure to the light stimulus
alone elicits a learned fear response (‘‘freezing’’ behavior)
(Li et al., 2012). We used three groups of animals for these
studies: WT mice and rd1 mice injected with either DENAQ or
sham at 6 hr before training. On day 1 (training day), we exposed
animals to either paired (three trials of 10 s light stimuli, each co-
terminating with a 2 s shock) or unpaired stimuli (the same light
and shock stimuli interleaved rather than overlapping). On day
2 (recall day), we presented the light stimulus alone (Figure 8A).
Sample recall trial movement traces of individual sham-injected
rd1 mice (left, black), DENAQ-injected rd1 mice (middle, blue),
andWTmice (right, red), all of whom had been exposed to paired
conditioning during day 1, are shown in Figure 8B. WT mice that
had received paired stimuli showed a decrease in locomotor ac-
tivity in response to light on recall day (n = 10; p < 0.001) (Figures
8B and 8C). In contrast, sham-injected rd1 mice showed no
change in locomotor activity in response to light (n = 9; p =
0.98) (Figures 8B and 8C). However, DENAQ-injected rd1 mice
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Figure 6. DENAQ Selectively Photosensitizes Ih in rd1, but Not WT, RGCs
(A and B) Current versus voltage relationships of RGCs from WT (A) and rd1 (B) retinas obtained in darkness (black) or in light (green or blue).
(C) Light-elicited current, defined as the difference between currents measured in light and dark in theWT RGC (from A) (green) and in the rd1RGC (from B) (blue).
(D) Light-elicited change in Ih (left) and IK (right) in WT RGCs (black) (n = 11) and in rd1 RGCs (blue) (n = 9), shown as percent difference. Ih was photoregulated in
rd1 (mean = 22%) RGCs, but not in WT RGCs (mean = 0.3%, p < 0.001). IK was photosensitized to the same extent in WT and rd1 RGCs (WT mean = 15%, rd1
mean = 23%; p = 0.2).
(E) Ih and IK current densities in WT (black) (n = 13 cells) and rd1 (blue) (n = 7) RGCs. Ih density was significantly higher in rd1 RGCs (mean = 6.4 pA/pF) than in WT
RGCs (mean = 2.9 pA/pF, p < 0.01). IK density was not significantly different (WT mean = 12.3 pA/pF, rd1 mean = 16.6 pA/pF; p = 0.3).
(F) DENAQ treatment photosensitizes rd1 RGCs (n = 8 retinas, mean firing rate increase [MFRI] = 3.53; p < 0.001) (left). Subsequent application of the Ih blockers
ZD7288 (n = 7 retinas, MFRI = 1.18; p = 0.38) (second from left), ivabradine (n = 4 retinas, MFRI = 1.01; p = 0.87) (second from right), or cilobradine (n = 4 retinas,
MFRI = 1.02; p = 0.81) (right) abolishes DENAQ-mediated rd1 RGC photosensitization. Mean ± SEM firing rates are shown in red.
(G) Mean light response index of DENAQ-treated rd1RGCs (mean LRI = 0.7) (blue). The Ih blockers ZD7288 (mean LRI = 0.02, p < 0.001) (black), ivabradine (mean
LRI = 0, p < 0.001) (red), and cilobradine (mean LRI = 0.01, p < 0.001) (green) eliminate DENAQ-mediated RGC photosensitization. Data are mean ± SEM.
See also Figures S3 and S4.
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Figure 7. DENAQ Restores Light-Modulated Open-Field Locomotor Behavior in Blind Mice
(A) Movement trajectory of the same rd1mouse exploring an open cylindrical cage in the dark (gray) and under 500 nm light (green) before (top) and after (bottom)
DENAQ injection.
(B) Cumulative distance traveled by an rd1 mouse before (left) and after (right) DENAQ injection.
(C) Bar graph of activity in the light divided by activity in darkness before (black) (n = 20 mice, mean = 1.04) and after intravitreal injection of DENAQ and before
(yellow) or after (gray) sham injection (n = 6 mice, p = 0.88). Activity ratios for the first 100 s of exploratory behavior of DENAQ-injected mice (blue) (mean = 1.73,
p < 0.001), 100–200 s in the light (green) (mean = 1.52, p < 0.001), and the final 100 s in the light (red) (200–300 s) (mean = 1.39, p < 0.05) are shown. The amount of
exploratory activity decreased with time. Data are mean ± SEM.
See also Figure S5.
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locomotor activity (i.e., freezing) in response to light (n = 10;
p < 0.001), to the same extent as conditioned WT mice (n = 10;
p = 0.51) (Figures 8B and 8C). DENAQ-injected rd1 mice that
had received unpaired stimuli showed no change in locomotor
activity in response to light. These results demonstrate that the
light perception conferred by DENAQ allows for visual learning,
first enabling mice to associate light with a fearful stimulus on
day 1 and then mediating the recall of the memory on day 2.
DISCUSSION
DENAQ as a Potential Treatment for Degenerative
Blinding Disease
DENAQ has none of the serious shortcomings exhibited by AAQ.
DENAQ has a red-shifted absorbance spectrum and therefore
photoisomerizes from trans to cis with light in the 400–550 nm
range, instead of the UV light required by AAQ. DENAQ photo-
sensitizes the blind rd1 retina to moderately bright white light,
similar in intensity to ordinary daylight. The compound lasts in
the eye for days following a single intravitreal injection. TUNEL
staining and histological analyses show no evidence of adverse
effects on the mouse retina. These features make DENAQ a
favorable photoswitch candidate for preclinical development808 Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc.as a potential therapeutic for human use. Additional studies
will be needed to assess acute toxicity potential in large mam-
mals having eyes that are structurally and functionally closer
to humans. Both safety and efficacy of photosensitization can
be assessed in several animal models of RP, including blind
strains of dogs (Petersen-Jones, 2005) and pigs (Li et al.,
1998). There are no suitable primate models of RP, but laser
ablation of photoreceptors can generate local scotomas that
have features in common with human blinding disease (Hunter
et al., 2012).
We delivered DENAQ in vivo by injecting it into the vitreous
cavity of the eye. Intravitreal drug administration in humans has
become commonplace. For example, antiangiogenesis drugs
for AMD are often administered in monthly injections (Martin
et al., 2012), which have proven to be safe (Ladas et al., 2009).
DENAQ persists in the eye for up to a week after a single injec-
tion. A slow release formulation involving biodegradable polymer
encapsulation (London et al., 2011) may extend the release life-
time of DENAQ to enable less frequent treatments (perhaps
monthly) to sustain photosensitization.
Nonetheless, the transient nature of DENAQ photosensitiza-
tion could be advantageous for minimizing possible adverse
effects. The impermanence would allow for adjustment of
dosage in individual patients to optimize vision restoration
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Figure 8. DENAQ Enables Visual Learning in Blind Mice
(A) Diagram of the paired, unpaired conditioning and recall protocols for the visual fear-conditioning assay. Electric foot shock (yellow) and light flash (blue)
episodes are shown.
(B) Cumulative distance traveled by a paired-conditioned sham-injected rd1mouse (left, black), a paired-conditioned DENAQ-injected rd1mouse (middle, blue),
and a paired-conditioned WT mouse (right, red) in the 30 s of darkness preceding the light flash and the subsequent 30 s in the light during the recall trial.
(C) Bar graph of activity in light divided by activity in darkness for sham-injected rd1 (n = 9, p = 0.71), DENAQ-injected rd1 (n = 10, p < 0.001), andWTmice (n = 10,
p < 0.001) during the recall trial. Data are mean ± SEM.
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end-stage RP patients with no light perception, DENAQ might
be useful for enhancing visual performance in low-vision patients
with advanced RP or AMD. Moreover, acute RGC photosensiti-
zation with DENAQ might be useful for evaluating the functional
integrity of the visual system in the brain before employing more
permanent therapies, such as retinal implants.
Our results demonstrate that DENAQ can restore innate and
learned visual behavioral responses in blind mice. We do not
know whether these mice are capable of visually recognizing
objects, but object recognition has not yet been demonstrated
for any vision-restoration technology implemented in blind
mice. It is likely that whatever technology is used, training will
lead to improvement in visual performance over time. Object
recognition in human RP patients receiving a retinal implant im-
proves dramatically with training (Humayun et al., 2012), similar
to the progressive improvement of hearing in profoundly deaf
patients outfitted with cochlear implants (Stacey et al., 2010). It
is thus encouraging that light perception conferred by DENAQ
is sufficient for visual learning and recall in blind mice.
Ideally, vision-restoration technologies should enable the
blind retina to respond to acceptable light intensities with suffi-
ciently rapid kinetics to enable detection of moving objects.
The kinetics of DENAQ-mediated responses are dependent onlight intensity, with bright light maximizing the speed of response
onset to less than 50 ms and dim light allowing reliable re-
sponses to more frequent flashes. Spontaneous relaxation of
DENAQ from cis to trans in darkness (t1/2) takes 300 ms
(Mourot et al., 2011), consistent with the DENAQ-mediated
RGC light response decaying within 1 s, on average. However,
the response kinetics vary considerably, and some RGCs
consistently turn off much quicker (<50 ms). In part, the speed
of movement detection will depend on how the visual system
weighs these different RGC responses. Novel azobenzene deriv-
atives with nanosecond thermal relaxation kinetics have been
developed (Garcia-Amoro´s et al., 2012), and photoswitches
incorporating these compounds may enable very-high-fre-
quency optical stimulation of neuronal firing.
The RGCs of DENAQ-treated blind mice all generate the same
polarity light response, in contrast to the dual on versus off light
responses generated by RGCs in normal functioning retinas, but
this should not be a serious problem for visual perception.
In human RP patients, electronic retinal implants can restore
object recognition, even though the implants indiscriminately
stimulate on and off RGCs (Humayun et al., 2012). DENAQmight
enable some degree of visual perception under real-world phot-
opic illumination conditions. However, image-altering projection
goggles could improve perception by tuning the intensity,Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc. 809
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visual experience.
Implications of Degeneration-Specific
Photosensitization
DENAQ has a profound effect on photoreceptor-degenerated
retinas from rd1 or rd4 mice while having little or no effect on
healthy retinas from WT or TKO mice. The degeneration-depen-
dent action suggests that DENAQ might selectively impart
photosensitivity when cell death is constrained to a particular re-
gion, e.g., the peripheral retina in RP or the central retina in AMD.
Our results imply that DENAQ will not interfere with normal pho-
totransduction and visual processing in regions of the retina that
are still healthy. The selective targeting of photosensitization to
diseased tissue could be an important clinical advantage.
Our experiments indicate that RGCs are the primary cellular
targets for DENAQ photosensitization in the retina. The DE-
NAQ-mediated light response is fully retained in RGCs after
blocking all synaptic transmission, indicating that bipolar and
amacrine cells are not required. We previously showed that the
dominant cell type for AAQ-mediated photosensitization is the
amacrine cell (Polosukhina et al., 2012). Light relieves AAQ
blockade of K+ channels in amacrine cells, hyperpolarizing the
membrane potential, but because amacrine cells are inhibitory,
the net effect is to enhance RGC firing. There are possible advan-
tages in converting RGCs into the direct transducers of light
input rather than relying on presynaptic neurons to transmit
this information. In principle, the latency of signaling to the brain
will be shorter with direct RGC stimulation, and the signal gener-
ated directly in RGCs is downstream of retinal circuit remodeling
that occurs during degeneration (Jones et al., 2012; Marc et al.,
2003), which could distort spatial representation of images.
Our results indicate that degeneration of rods and cones in the
outer retina somehow leads to changes in the electrophysiology
of RGCs in the inner retina, enabling DENAQ photosensitization.
We do not know whether the change in RGCs is triggered by the
loss of light-driven synaptic input or trophic factor signaling.
Morphological and electrophysiological changes in RGCs, re-
sulting from degeneration, have been reported (Jones et al.,
2012; Marc et al., 2003; Sekirnjak et al., 2011), but our results
point to a previously unrecognized change in Ih as being the
crucial alteration that enables DENAQ photosensitization.
Ih is a hyperpolarization-activated inward current that gener-
ates rebound depolarization after spikes, sustaining repetitive
activity in cardiacmyocytes and neurons (Lewis and Chetkovich,
2011). Our results show a 2-fold increase of Ih in rd1 RGCs,
helping to explain why these neurons are hyperactive in degen-
erating retina. However, it is unclear whether the increase in cur-
rent density alone accounts for the enormous increase in DENAQ
photosensitivity or whether additional changes in channel prop-
erties are involved. There are four hyperpolarization-activated
cyclic nucleotide-gated (HCN) channel subunits, HCN1–4, that
underlie Ih in different cell types (Lewis and Chetkovich, 2011;
Postea and Biel, 2011). RGCs normally express HCN1 and
HCN4 (Stradleigh et al., 2011), and both of these channels can
be photosensitized by DENAQwhen expressed as homomultim-
ers in HEK293 cells (unpublished data). In addition to changes in
channel expression, it is possible that a change in HCN channel810 Neuron 81, 800–813, February 19, 2014 ª2014 Elsevier Inc.localization or subunit composition or a change in auxiliary
subunits, such as TRIP8b (Santoro et al., 2009), might alter the
sensitivity of Ih to DENAQ.
DENAQ photosensitizes Ih and voltage-gated K
+ channels in
RGCs from rd1 retina. Unlike K+ channels, which are found in
virtually every cell type in the eye, HCN channels are highly
restricted to neurons (Mu¨ller et al., 2003). Different azobenzene
photoswitches have overlapping but distinct selectivities for
voltage-gated ion channels (Mourot et al., 2013). Thus, it may
be possible to engineer a photoswitch compound that is specific
for Ih, either by modifying chemical moieties in DENAQ or by
adding a light-sensitive azobenzene to a selective HCN ligand,
such as ivabradine. A photoswitch specific for Ih would have
the advantage of enabling photoregulation of neurons while hav-
ing no effect on other cell types. By targeting Ih, we have uncov-
ered a strategy for restoring visual function, based on exploiting
changes in the endogenous electrophysiology of neurons that
have remodeled during the progression of retinal degeneration.
EXPERIMENTAL PROCEDURES
Chemicals
Photoswitch compounds were synthesized as formate salts in accordance
with previously described protocols (Fortin et al., 2008; Mourot et al., 2011).
All other chemicals were purchased from Sigma-Aldrich or Tocris Bioscience.
Animals
WT mice (C57BL/6J strain, Jackson Laboratory), homozygous rd1/rd1 mice
(C3H/HeJ strain, Charles River Laboratories), heterozygous rd4/+ mice
(In56Rk-Rd4 strain, Jackson Laboratory), and triple-knockout mice (tra/
cnga3/ opn4/, a gift of King-Wai Yau, Johns Hopkins University) 3–
6 months old were used in the MEA experiments. All animal use procedures
were approved by the UC Berkeley Institutional Animal Care and Use
Committee.
Multielectrode Array Electrophysiology
Retinas were dissected and kept in physiological saline (artificial cerebrospinal
fluid [ACSF]) at 37C containing (in mM) 119 NaCl, 2.5 KCl, 1 KH2PO4, 1.3
MgCl2, 2.5 CaCl2, 26.2 NaHCO3, and 20 D-glucose, aerated with 95% O2/
5% CO2. A solution containing (in mM) 10 AP4, 40 DNQX, 30 AP5, 10 SR-
95531 (GABAzine), 50 TPMPA, 10 strychnine, and 50 tubocurarine was used
in experiments where we wished to pharmacologically isolate RGCs from
outer retinal synaptic inputs. For extracellular recordings, a flat-mounted retina
or a series of 400-mm-wide transverse retinal slices made with a sharp razor
blade were placed ganglion cell layer down onto an MEA system (MEA
1060-2-BC,Multi-Channel Systems). TheMEA electrodeswere 30 mm in diam-
eter, spaced 200 mm apart, and arranged in an 83 8 rectangular grid. Retinas
were treated with 300 mMDENAQ in the MEA chamber for 30 min, followed by
a 15 min wash. In order to pharmacologically isolate RGCs, the synaptic
blocker cocktail (in ACSF) was subsequently perfused for 15 min. Ih was
blocked by a 30 min perfusion of 100 mM ZD7288, 50 mM ivabradine, or
50 mM cilobradine (in ACSF with or without synaptic blockers). Extracellular
spikes were high-pass filtered at 200 Hz and digitized at 20 kHz. A spike
threshold of 4 SDwas set for each channel. Typically, each electrode recorded
spikes from one to three RGCs. Principal component analysis of the spike
waveforms was used for sorting spikes generated by individual cells (Offline
Sorter, Plexon).
Patch-Clamp Electrophysiology
Borosilicate glass electrodes with resistance of 4–6 MU were used for all
voltage clamp recordings. Access resistance was 5–14 MU. For measuring
voltage-gated Ih and K
+ currents, electrodes contained (in mM) 116 K+
gluconate, 6 KCl, 2 NaCl, 20 HEPES, 0.5 EGTA, 4 ATP-Mg, 0.3 GTP-Na2,
and 10 phosphocreatine-Na2. The ACSF solution was the same as the
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200 mM DENAQ for 40 min in ACSF at 25C, followed by a 15 min wash.
Synaptic inputs were blocked with a solution containing the same synaptic
blockers as those used in the MEA experiments in addition to 1 mM tetrodo-
toxin-citrate. Current amplitudes for current-voltage relationships were
measured as averages over 50 ms at the end of voltage test pulses applied
from the holding potential Vh = 60 mV to 100 mV and then stepping up to
0 mV in 10 mV increments every 1 s. Two sets of I-V measurements were
made in the dark and under 480 nm light and averaged to calculate percent
change in current. Photoregulation of Ih was quantified at 100 mV and pho-
toregulation of IK at 0 mV.
Light Stimulation
A 100 W arc lamp (Ushio USH-103D) was used for MEA light stimulation. The
photon flux equivalent for DENAQ-treated retinas was calculated using 470 nm
(photoswitch absorbance peak) photon energy. The incident white light inten-
sity for rd1, WT, and TKO retinas was 3.3 3 1015 photons/cm2/s and 3 3 1014
photons/cm2/s for rd4 retinas, unless stated otherwise. AAQ-treated retinas
were stimulated with filtered 380 nm and 500 nm light from the same lamp us-
ing narrow-band filters (Chroma), with the same light intensity as previously
described (Polosukhina et al., 2012). A Polychrome V (Till Photonics GmbH)
monochromator was used to determine the action spectrum of DENAQ in
the retina. The action spectrum was corrected for photon flux at each individ-
ual wavelength. The Polychrome was also used to deliver 3.63 1015 photons/
cm2/s of 480 nm light to RGCs in patch-clamp experiments. A typical MEA
stimulation protocol consisted of ten cycles of alternating 15 s light/dark
intervals.
Data Analysis and Statistics
We calculated the average RGC firing rate for individual retinas in light and in
darkness in some experiments. In order to normalize light-elicited changes in
firing rate of individual RGCs in rd1, rd4, and TKO retinas, we calculated the
LRI = (mean firing rate in the light  mean firing rate in darkness)/(mean firing
rate in the light + mean firing rate in darkness). Light-elicited changes in firing
rate of individual RGCs inWT retinas were calculated as PLRI = (peak firing rate
in the light  peak firing rate in darkness)/(peak firing rate in the light + peak
firing rate in darkness). The first second of the light and dark intervals was
used to measure the peak firing rate. Pairwise comparisons of LRI and PLRI
distributions were performed using the Wilcoxon rank sum test (Matlab). All
other statistical significance (p value) calculations were performed using the
two-tailed unpaired Student’s t test. Results with p < 0.05 were considered
significant.
Intravitreal Injections
Before injection, animals were anesthetized with isoflurane (2%) and their
pupils were dilated with tropicamide (1%). An incision was made through the
sclera, below the ora serrata with a 30G needle and 2 ml of either DENAQ
(2 ml of various concentrations of DENAQ in 90% PBS/10% DMSO) or vehicle
only (sham) (2 ml of 90%PBS/10%DMSO) was injected into the vitreous with a
blunt-ended 32G Hamilton syringe. The mice were allowed to recover for 6 hr
after injection with open access to food and water in their cage.
Cryosections
WT mice were euthanized by CO2 asphyxiation and cervical dislocation 10 or
30 days after intravitreal injection. For each mouse, one eye was injected with
5 mM DENAQ and the other eye was injected with sham. For retinal cross sec-
tions, the animals were enucleated, the cornea and lens were removed, and
the resulting eye cups were fixed in 4% paraformaldehyde for 1 hr at room tem-
perature. The tissueswere then cryoprotected in30%sucroseovernight at 40C
and frozen inoptimumcutting temperaturecompound (Tissue-TEK,Sakura)with
dry-ice ethanol slurry. Retinal sections were cut (15 mm) with a Microm HM550
cryostat (Thermo Scientific) and collected on Superfrost Plus slides (Menzel
Glaser). Four sections from both retinas were collected on the same slide.
Histology
TUNELwas used to assess apoptosis in retinal slices. Slideswere treated using
an in situ cell death detection kit, Fluorescein (Roche), following the manufac-turer’s instructions for cryopreserved tissue. Positive and negative TUNEL
control sections (DNase I-treated sections and sections without terminal deox-
ynucleotidyl transferase) were included on each slide. Slides were then stained
with 1 mMDAPI in PBS (Gibco; pH 7.4). Fluoromount-G (Southern Biotech) was
used tomount coverslipsontoslides. Slideswere imagedonanOlympusVS120
slide scanner through a 403 air objective using DAPI and fluorescein isothiocy-
anate filters. Images were analyzed using ImageJ. Each section was broken up
into 2503 250mmfields of roughly equal cell number, and three fields fromeach
section were randomly chosen. Apoptotic cells were identified by colocalized
DAPI and fluorescein signals. Thickness of nuclear layers was measured at
four equidistant positions along the image and averaged. Retinal ganglion cells
were counted over a 100 mm section. Two counts were made and averaged.
Open-Field Test
Rd1mice were placed in a 1903 100 mm circular chamber. The chamber was
surrounded by six panels of 500 nmLEDs (Roithner Laserteknik), providing uni-
form illumination with a light intensity of 2.5 3 1016 photons/cm2/s. The mice
were dark-adapted for 1 hr and habituated to the experimental chamber for
5 min prior to each experiment. Exploratory behavior was recorded using an
infrared (IR)-sensitive videocamera (LogitechC310) for 5min indarkness under
IR illumination, then the chamber was illuminated by the 500 nm LEDs, and
mouse locomotion was monitored for an additional 5 min. The apparatus was
cleaned after each experiment. Eachmousewas tested oncebefore intravitreal
injection and again 6 hr after injection of either 20 mMDENAQ or sham. Videos
were analyzed with motion-tracking software (Tracker) to record the animals’
velocity and position. The ratio of activity light/activity dark was defined as
mean velocity in the light/mean velocity in darkness.
Visual Fear-Conditioning Test
Fear conditioning was conducted in a 123 103 12 in chamber with an electri-
fied metal bar floor (Coulbourn Instruments). Prior to the experiment, animals
were habituated by handling intervals interspersed over 2 days and with a
5 min exposure to the chamber. On day 1, groups of WT mice, sham-injected
rd1 mice, or DENAQ-injected rd1 mice (6 hr after intravitreal injection of
10 mM DENAQ or sham) were subjected to paired stimuli or unpaired stimuli.
Paired conditioning consisted of a 5min habituation period in thedark, followed
by three 10 s white light stimuli each coterminating with a 2 s foot shock, with
15 s between light flashes. Unpaired conditioning was identical except that
the three foot shocks and three light stimuli were interleaved with 5–12 s
between stimuli. On day 2, the mice were tested for recall of the light-cued
conditioning. The recall trial consisted of a 5 min habituation period in the
dark followed by a 30 s white-light stimulus. The apparatus was cleaned after
each experiment. Two house lights provided dim illumination (1 3 1013 pho-
tons/cm2/s) sufficient to allow video recording throughout the experiment but
below the threshold for DENAQ activation. The bright-light cue was provided
by twowhite-LEDarrays attached to the inner-chamber ceiling (1.131015 pho-
tons/cm2/s). Locomotor activity was analyzed as in the open-field assay.
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